Search Results
Retinal atrophy independent of optic neuritis in AQP4+ NMOSD
Retinal atrophy as a biomarker in multiple sclerosis
Predictors of early serologic diagnosis of AQ4-IgG positive NMOSD
Updates on N-MOmentum: inebilizumab versus placebo in patients with NMOSD
Dr. Anu Jacob l NMOSD Therapy Update
Webinar: Inflammation and retinal degeneration in retinitis pigmentosa
Socioeconomic disparity is associated with faster retinal neurodegeneration in multiple sclerosis
Prognostic factors in NMOSD: age, ethnicity, and relapse history
PREVENT study: eculizumab in AQP4-IgG-positive NMOSD
Retinal Atrophy- gradual blindness
SPHERES: collecting real-world data to explore disease characteristics & clinical outcomes in NMOSD
Retina Imaging - December 1, 2021
